Key facts
- This page summarizes DEERFIELD MANAGEMENT COMPANY, L.P.'s Form 4 filing for DA32 Life Science Tech Acquisition Corp..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 Aug 2023, 17:24.
DEERFIELD MANAGEMENT COMPANY, L.P. - 28 Jul 2023 Form 4 Insider Report for DA32 Life Science Tech Acquisition Corp.
- Reporting relationship
- Director, Director by Deputization, 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 28 Jul 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Aug 2023, 17:24:40 UTC
- Prior SEC filing
- 09 Aug 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jonathan Isler, Attorney-in-Fact for Deerfield Management Company, L.P.
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
DEERFIELD MANAGEMENT COMPANY, L.P. filed Form 4 for DA32 Life Science Tech Acquisition Corp. on 01 Aug 2023.
Change
- Previous filing in this sequence was filed on 09 Aug 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DALS
transaction
Class A Common Stock
Other
- Transaction value
- Shares
- -1,600,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 28 Jul 2023
- Ownership
- Through Deerfield Partners, L.P.
- Footnotes
- F1, F2, F3
DALS
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 650,000
- Date
- 28 Jul 2023
- Ownership
- Through DA32 Sponsor LLC
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
On July 28, 2023, the Issuer redeemed all of its outstanding shares of Class A common stock for a redemption price of approximately $10.31 per share.
Footnote F2
This Form 4 is filed jointly by Deerfield Partners, L.P. ("Deerfield Partners"), Deerfield Mgmt, L.P. ("Deerfield Mgmt"), Deerfield Management Company, L.P. (Deerfield Management") and James E. Flynn (collectively, the "Reporting Persons"). Deerfield Mgmt is the general partner of Deerfield Partners. Deerfield Management is the investment manager of Deerfield Partners. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt and Deerfield Management.
Footnote F3
In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by Deerfield Partners and DA32 Sponsor LLC ("Sponsor") is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
Footnote F4
As one of three managing members of Sponsor, Deerfield Partners may be deemed to beneficially own the securities owned directly by Sponsor. As the general partner of Deerfield Partners, Deerfield Mgmt may be deemed to beneficially own the securities owned directly by Sponsor. As the investment manager of Deerfield Partners, Deerfield Management may be deemed to beneficially own securities owned directly by Sponsor. As the sole member of the general partner of each of Deerfield Management and Deerfield Mgmt, James E. Flynn may be deemed to beneficially own the securities owned directly by Sponsor. The Sponsor and other members of the Sponsor are separately filing a Form 4 with respect to the securities reported herein.
SEC remarks
Andrew ElBardissi, an employee of Deerfield Management Company, serves as a director of the Issuer. Jonathan Isler, Attorney-in-Fact: Power of Attorney, which is hereby incorporated by reference to Exhibit 24 to a Form 4 with regard to DA32 Life Science Tech Acquisition Corp. filed with the Securities and Exchange Commission on August 3, 2021 by Deerfield Partners, L.P., Deerfield Mgmt, L.P., Deerfield Management Company, L.P. and James E. Flynn.